This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Nagasaki University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Satoshi Mizuta: Innovator in Biopharmaceuticals
Introduction
Satoshi Mizuta is a prominent inventor based in Nagasaki, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that enhance cellular cytotoxicity and proliferation. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Mizuta holds two notable patents. The first patent is for a fluorine-containing bisphosphonic acid derivative and its applications. This invention involves a series of fluorine-containing bisphosphonic acids that include an alkylamine side chain and various heterocyclic groups. These compounds are designed to efficiently induce the proliferation of peripheral blood γδ T cells, which exhibit superior cytotoxicity against tumor cells and virus-infected cells. The second patent is a rapid method for measuring cytotoxicity in a non-radioactive system. This invention provides a novel compound for accurately measuring cellular cytotoxicity or cell proliferation capacity with high reproducibility and convenience.
Career Highlights
Satoshi Mizuta is affiliated with Nagasaki University, where he conducts his research and development activities. His work has garnered attention in the scientific community, particularly for its potential applications in cancer immunotherapy and virology. His innovative approaches have positioned him as a key figure in the field of biopharmaceutical research.
Collaborations
Mizuta collaborates with esteemed colleagues, including Yoshimasa Tanaka and Hiroshi Ueda. These partnerships enhance the scope and impact of his research, fostering a collaborative environment that drives innovation.
Conclusion
Satoshi Mizuta's contributions to biopharmaceuticals through his patents and research at Nagasaki University highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile